Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK

Journal of Diabetes and its Complications

Volumn 22, Issue 4, 2008, Pages 235-240

  Yurgin, Nicole ^a   Secnik, Kristina ^a   Lage, Maureen J ^b  

^a ELI LILLY AND COMPANY   (United States)

^b HealthMetrics Outcomes Research LLC   (United States)

Author keywords

Diabetes; Insulin; Obesity; Type 2; UK

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCRIPTION; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; UNITED KINGDOM;

AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 45849106864     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.12.001     Document Type: Article

References (30)

1. American Diabetes Association. Clinical practice recommendations 2001. Diabetes Care 24 Suppl 1 (2001) S1-S133
2. Burgers J.S., Bailey J.V., Klazinga N.S., Van der Bij A.K., Grol R., and Feder G. Inside Guidelines: Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 25 (2002) 1933-1939
3. Chutka D.S., Takahashi P.Y., and Hoel R.W. Inappropriate medication use in the elderly. Essential Psychopharmacology 6 6 (2005) 331-340
4. Department of Health. Investing in general practice: The new general medical services contracts (2003). http://www.dh.gov.uk/assetRoot/04/07/19/67/04071967.pdf [Accessed July 2006]
5. Federal Chamber of Physicians. National guideline for diabetes mellitus type 2, abridged version. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung 96 Suppl 2 (2002) 1-23
6. Flier J.S. Obesity. In: Kahn R.C., and Weir G.C. (Eds). Joslin's diabetes mellitus. 13th ed (1994), Lea & Febiger, Philadelphia, PA 351-361
7. Fry J., and Finley W. The prevalence and costs of obesity in the EU. Proceedings of the Nutrition Society 64 3 (2005) 359-362
8. Greenfield J.R., Samara K., Hayward C.S., Chisholm D.J., and Campbell L.V. Beneficial postprandial effect of small amount of alcohol on diabetes and cardiovascular risk factors: Modification by insulin resistance. Journal of Clinical Endocrinology and Metabolism 90 2 (2005) 661-672
9. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 65 Suppl 1 (2004) S23-S27
10. Hughes C.M. Medication non-adherence in the elderly: How big is the problem?. Drugs & Aging 21 12 (2004) 793-811
11. Kamholz S.L. Pulmonary and cardiovascular consequences of smoking. Clinics in Occupational and Environmental Medicine 5 1 (2005) 157-171
12. Larger E. Weight gain and insulin treatment. Diabetic Medicine 31 4 Pt 2 (2005) 4S51-4S56
13. Lewis J.D., and Brensinger C. Agreement between GPRD smoking data: A survey of general practitioners and a population-based survey. Pharmacoepidemiology and Drug Safety 13 7 (2004) 437-441
14. Liebl A., Neiss A., Spannheimer A., Reitberger U., Wieseler B., Stammer H., et al. Complications, co-morbiditiy, and blood glucose control in type 2 diabetes mellitus patients in Germany-Results from the CODE-2 study. Experimental and Clinical Endocrinology & Diabetes 100 1 (2002) 10-16
15. Lundman B.M., Asplun K., and Norberg A. Smoking and metabolic control in patients with insulin-dependent diabetes mellitus. Journal of Internal Medicine 227 2 (1990) 101-106
16. Lyratzopoulos G., Heller R.F., McElduff P., Hanily M., and Lewis P.S. Deprivation and trends in blood pressure, cholesterol, body mass index and smoking among participants of a UK primary-care based cardiovascular risk factor screening programme: Both narrowing and widening in cardiovascular risk factor inequities. Heart (2006, Feb) [Epub ahead of print]
17. Mason C., Katzmarzyk P.T., and Blair S.N. Eligibility for obesity treatment and risk of mortality in men. Obesity Research 13 10 (2005) 1803-1809
18. Meltzer S., Leiter L., Daneman D., Gerstein H.C., Lau D., Ludwig S., et al. Clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ: Canadian Medical Association Journal 159 Suppl 8 (1998) S1-S29
19. Monnier L., and Collete C. Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: Indications and modalities. Diabetes & Metabolism 32 (2006) 7-13
20. National Institute for Clinical Excellence. Management of type 2 diabetes: Managing blood glucose levels. Available at: (2002). www.nice.org.uk [Accessed July 2006]
21. National Statistics, UK (2001). http://www.statistics.gov.uk/StatBase/ssdataset.asp?vlnk=7447&More=Y [accessed July 2006].
22. Rennie K.L., and Jebb S.A. Prevalence of obesity in Great Britain. Obesity Reviews 6 1 (2005) 11-12
23. Salle A., Ryan M., Guilloteau G., Bouhanick B., Berrut G., and Ritz P. 'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients. British Journal of Nutrition 94 6 (2005) 931-937
24. Simonson W., and Feinberg J.L. Medication-related problems in the elderly: Defining the issues and identifying solutions. Drugs & Aging 22 7 (2005) 559-569
25. Tsai S.P., Donnelly R.P., and Wendt J.K. Obesity and mortality in a prospective study of a middle-aged industrial population. Journal of Occupational and Environmental Medicine 48 1 (2006) 22-27
26. UK Department of Health. Investing in general practice: The new general medical services contract. Annex A: Quality indicators. Available at: (2003). http://www.dh.gov.uk/PolicyandGuidance/OranisationPolicy/PrimaryCare/PrimaryCareContracting/GMS/fs/en [Accessed July 2006]
27. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
28. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
29. Woods L., and Coulson R. Revitalizing the General Practice Research Database: Plans, challenges, and opportunities. Pharmacoepidemiology and Drug Safety 10 (2001) 379-383
30. World Health Organization. Global strategy on diet, physical activity and health: Obesity and overweight (2003). http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/ [Accessed July 2006]